LYON, France--(BUSINESS WIRE)--Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial ...

Explore the unique mechanisms of bispecific antibodies and their rapid availability compared to CAR T-cell therapies in cancer treatment.

As clinical research evolves at an unprecedented pace, it’s important that physicians understand how emerging trends may ...

New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures PHILADELPHIA, Jan. 6, 2026 /PRNewswire/ -- ...

TrialAssure, a leading technology provider advancing clinical trial transparency, disclosure, and data sharing, announced ...

Five hundred people in the Canadian province of New Brunswick were diagnosed with a "mystery brain disorder" that resembled ...

2025 FEB 11 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News-- New research on Information Technology - Data Management is the subject of a report. According to news reporting ...

Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party algorithms and Dandelion's data platform and model validation capabilities to ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

Candel Therapeutics, Inc. recently announced positive results from its clinical trials, highlighting the efficacy of its investigational therapies CAN-2409 and CAN-3110 in treating various cancers.

SHANGHAI, May 23, 2025 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced multiple clinical research results to be presented at ...